Literature DB >> 6803981

Interaction of azapropazone with phenytoin.

D P Geaney, J G Carver, J K Aronson, C P Warlow.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6803981      PMCID: PMC1498229          DOI: 10.1136/bmj.284.6326.1373

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  5 in total

1.  The determination of azapropazone in blood plasma.

Authors:  H Leach
Journal:  Curr Med Res Opin       Date:  1976       Impact factor: 2.580

Review 2.  Drug interactions with phenytoin.

Authors:  E Perucca; A Richens
Journal:  Drugs       Date:  1981-02       Impact factor: 9.546

3.  Anticonvulsant intoxication precipitated by azapropazone.

Authors:  C J Roberts; T K Daneshmend; D Macfarlane; P A Dieppe
Journal:  Postgrad Med J       Date:  1981-03       Impact factor: 2.401

4.  Hypoglycaemia induced by azapropazone-tolbutamide interaction.

Authors:  P B Andreasen; K Simonsen; K Brocks; B Dimo; P Bouchelouche
Journal:  Br J Clin Pharmacol       Date:  1981-10       Impact factor: 4.335

5.  Antipyretic analgesics in patients on antiepileptic drug therapy.

Authors:  P J Neuvonen; R Lehtovaara; A Bardy; E Elomaa
Journal:  Eur J Clin Pharmacol       Date:  1979-05-21       Impact factor: 2.953

  5 in total
  4 in total

Review 1.  Pharmacokinetic drug interactions with phenytoin (Part II).

Authors:  R L Nation; A M Evans; R W Milne
Journal:  Clin Pharmacokinet       Date:  1990-02       Impact factor: 6.447

2.  Pharmacokinetic investigation of the interaction of azapropazone with phenytoin.

Authors:  D P Geaney; J G Carver; C L Davies; J K Aronson
Journal:  Br J Clin Pharmacol       Date:  1983-06       Impact factor: 4.335

3.  Comparison of phenytoin and gold as second line drugs in rheumatoid arthritis.

Authors:  I M Richards; S M Fraser; J A Hunter; H A Capell
Journal:  Ann Rheum Dis       Date:  1987-09       Impact factor: 19.103

Review 4.  Clinical pharmacokinetics of non-steroidal anti-inflammatory drugs.

Authors:  R K Verbeeck; J L Blackburn; G R Loewen
Journal:  Clin Pharmacokinet       Date:  1983 Jul-Aug       Impact factor: 6.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.